β¨ Health and Fisheries Notices
29 JULY NEW ZEALAND GAZETTE 2077
Commercial Fisheries Services Business Unit of Datacom Employer Services Limited, pursuant to the Registry Services Agreement.
Dated at Wellington this 26th day of July 1999.
WARWICK TUCK, Chief Executive, Ministry of Fisheries.
go5485
Health
Medicines Act 1981
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Trade Name: Apo-Oxybutynin.
Active Ingredient(s): Oxybutynin hydrochloride 1 mg/mL.
Dosage Form: Syrup.
NZ Sponsor: Apotex (NZ) Limited.
Manufacturer(s): Novex Pharma Inc, Richmond Hill, Ontario, Canada.
Dated this 19th day of July 1999.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go5395
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Aggrastat.
Active Ingredient(s): Tirofiban hydrochloride (monohydrate) 0.05618 mg/mL.
Dosage Form: Solution for infusion.
NZ Sponsor: Merck Sharp & Dohme (New Zealand) Limited.
Manufacturer(s): Baxter Healthcare Corporation, Marion, North Carolina, United States of America.
Product: Aggrastat.
Active Ingredient(s): Tirofiban hydrochloride (monohydrate) 0.281 mg/mL.
Dosage Form: Concentrate for infusion.
NZ Sponsor: Merck Sharp & Dohme (New Zealand) Limited.
Manufacturer(s): Ben Venue Laboratories Inc, Bedford, Ohio, United States of America.
Product: Klacid Hp7 (Combination Product).
Active Ingredient(s): Omeprazole 20 mg.
Dosage Form: Capsule.
Manufacturer(s): Astra Pharmaceutical Production AB, Strangnasvagen 44, Sodertalje, Sweden; and Astra Pharmaceuticals Limited, Headway, Great Oakley, Corby, Northamptonshire, United Kingdom.
Active Ingredient(s): Amoxycillin (trihydrate) 573.96 mg.
Dosage Form: Capsule.
Manufacturer(s): Apo-Biotics Inc., Weston, Ontario, Canada.
Active Ingredient(s): Clarithromycin 500 mg.
Dosage Form: Film coated tablet.
Manufacturer(s): Abbott Laboratories (UK) Limited, Queensborough, Kent, England; Abbott SpA, Campoverde di Aprilia, Latina, Italy; and Abbott Australasia Pty Limited, Kurnell, New South Wales, Australia.
NZ Sponsor: Abbott Laboratories (NZ) Limited.
Product: Losec Hp7 OAC (Combination Product).
Active Ingredient(s): Omeprazole 20 mg.
Dosage Form: Capsule.
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1999, No 87
NZLII —
NZ Gazette 1999, No 87
β¨ LLM interpretation of page content
πΎ
The Ministry and Datacom Employer Services Limited Registry Services Notice 1999
(continued from previous page)
πΎ Primary Industries & Resources26 July 1999
Registry services, Fisheries Act 1996, Datacom Employer Services Limited
- WARWICK TUCK, Chief Executive, Ministry of Fisheries
π₯ Consent to the Distribution of a New Medicine (Apo-Oxybutynin)
π₯ Health & Social Welfare19 July 1999
Medicines Act 1981, New Medicine, Consent, Distribution, Apo-Oxybutynin, Oxybutynin hydrochloride
- G. R. BOYD, Chief Advisor, Safety and Regulation
π₯ Consent to the Distribution of New Medicines (Aggrastat and Klacid Hp7)
π₯ Health & Social WelfareMedicines Act 1981, New Medicine, Consent, Distribution, Aggrastat, Tirofiban hydrochloride, Klacid Hp7, Omeprazole, Amoxycillin, Clarithromycin